 Connection
Fiona Zwald to Skin Neoplasms
This is a "connection" page, showing publications Fiona Zwald has written about Skin Neoplasms.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
2.685 |
|
|
|
-
Zwald FO, Sargen MR, Austin AA, Hsieh MC, Pawlish K, Li J, Lynch CF, Yu KJ, Engels EA. Outcomes in solid organ transplant recipients with a pretransplant diagnosis of melanoma. Am J Transplant. 2024 Jun; 24(6):993-1002.
Score: 0.501
-
Zwald F, Carvajal RD, Walker J, Sawinski D, Al-Adra D. Analysis of malignant melanoma risk and outcomes in solid organ transplant recipients: Assessment of transplant candidacy and the potential role of checkpoint inhibitors. Clin Transplant. 2021 05; 35(5):e14264.
Score: 0.408
-
Zwald F, Leitenberger J, Zeitouni N, Soon S, Brewer J, Arron S, Bordeaux J, Chung C, Abdelmalek M, Billingsley E, Vidimos A, Stasko T. Recommendations for Solid Organ Transplantation for Transplant Candidates With a Pretransplant Diagnosis of Cutaneous Squamous Cell Carcinoma, Merkel Cell Carcinoma and Melanoma: A Consensus Opinion From the International Transplant Skin Cancer Collaborative (ITSCC). Am J Transplant. 2016 Feb; 16(2):407-13.
Score: 0.287
-
Zwald F. Practice gaps. Immediate curettage and electrodessication following biopsy of suspected basal cell carcinoma at initial visit. JAMA Dermatol. 2013 Aug; 149(8):981.
Score: 0.241
-
Zwald F. Practice gaps. Toward a better definition of high-risk cutaneous squamous cell carcinoma: comment on "Factors predictive of recurrence and death from cutaneous squamous cell carcinoma". JAMA Dermatol. 2013 May; 149(5):547-8.
Score: 0.237
-
Zwald FO, Spratt M, Lemos BD, Veledar E, Lawrence C, Marshall Lyon G, Chen SC. Duration of voriconazole exposure: an independent risk factor for skin cancer after lung transplantation. Dermatol Surg. 2012 Aug; 38(8):1369-74.
Score: 0.221
-
McCoppin HH, Christiansen D, Stasko T, Washington C, Martinez JC, Brown MD, Zwald FO. Clinical spectrum of atypical fibroxanthoma and undifferentiated pleomorphic sarcoma in solid organ transplant recipients: a collective experience. Dermatol Surg. 2012 Feb; 38(2):230-9.
Score: 0.215
-
Greenberg JN, Zwald FO. Management of Skin Cancer in Solid-organ Transplant Recipients: A Multidisciplinary Approach. Dermatol Clin. 2011 Apr; 29(2):231-41, ix.
Score: 0.205
-
Massey PR, Schmults CD, Li SJ, Arron ST, Asgari MM, Bouwes Bavinck JN, Billingsley E, Blalock TW, Blasdale K, Carroll BT, Carucci JA, Chong AH, Christensen SR, Chung CL, DeSimone JA, Ducroux E, Escutia-Muñoz B, Ferrándiz-Pulido C, Fox MC, Genders RE, Geusau A, Gjersvik P, Hanlon AM, Olasz Harken EB, Hofbauer GFL, Hopkins RS, Leitenberger JJ, Loss MJ, Del Marmol V, Mascaró JM, Myers SA, Nguyen BT, Oliveira WRP, Otley CC, Proby CM, Rácz E, Ruiz-Salas V, Samie FH, Seçkin D, Shah SN, Shin TM, Shumack SP, Soon SL, Stasko T, Zavattaro E, Zeitouni NC, Zwald FO, Harwood CA, Jambusaria-Pahlajani A. Consensus-Based Recommendations on the Prevention of Squamous Cell Carcinoma in Solid Organ Transplant Recipients: A Delphi Consensus Statement. JAMA Dermatol. 2021 Oct 01; 157(10):1219-1226.
Score: 0.106
-
Que SKT, Zwald FO, Schmults CD. Cutaneous squamous cell carcinoma: Incidence, risk factors, diagnosis, and staging. J Am Acad Dermatol. 2018 02; 78(2):237-247.
Score: 0.082
-
Que SKT, Zwald FO, Schmults CD. Cutaneous squamous cell carcinoma: Management of advanced and high-stage tumors. J Am Acad Dermatol. 2018 02; 78(2):249-261.
Score: 0.082
-
Blechman AB, Cabell CE, Weinberger CH, Duckworth A, Leitenberger JJ, Zwald FO, Russell MA. Aggressive Skin Cancers Occurring in Patients Treated With the Janus Kinase Inhibitor Ruxolitinib. J Drugs Dermatol. 2017 May 01; 16(5):508-511.
Score: 0.078
-
Que SKT, Zwald FO, Schmults CD. Reply to: "Cutaneous squamous cell carcinoma progression during imiquimod treatment". J Am Acad Dermatol. 2018 07; 79(1):e13.
Score: 0.021
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|